Sumitomo Mitsui Financial Group Inc. Has $22.35 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Sumitomo Mitsui Financial Group Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 44,174 shares of the healthcare conglomerate's stock after buying an additional 2,469 shares during the period. Sumitomo Mitsui Financial Group Inc.'s holdings in UnitedHealth Group were worth $22,346,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of UNH. Soundwatch Capital LLC boosted its stake in shares of UnitedHealth Group by 5.7% in the 4th quarter. Soundwatch Capital LLC now owns 1,922 shares of the healthcare conglomerate's stock worth $972,000 after buying an additional 104 shares during the last quarter. Ashburton Jersey Ltd boosted its position in UnitedHealth Group by 4,457.9% in the fourth quarter. Ashburton Jersey Ltd now owns 12,762 shares of the healthcare conglomerate's stock worth $6,456,000 after purchasing an additional 12,482 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $30,000. Titleist Asset Management LLC boosted its holdings in shares of UnitedHealth Group by 42.2% in the 4th quarter. Titleist Asset Management LLC now owns 2,076 shares of the healthcare conglomerate's stock worth $1,050,000 after buying an additional 616 shares during the last quarter. Finally, Himension Capital Singapore PTE. LTD. purchased a new stake in UnitedHealth Group during the fourth quarter worth about $3,302,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company's stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Down 2.9 %

Shares of NYSE:UNH opened at $524.94 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a fifty day moving average of $509.24 and a 200 day moving average of $541.85. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The firm has a market capitalization of $480.17 billion, a PE ratio of 33.87, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 earnings per share. The company's quarterly revenue was up 6.8% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Barclays dropped their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research note on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.